Amicus Therapeutics 2024 Annual Meeting Invitation

Ticker: FOLD · Form: DEF 14A · Filed: Apr 24, 2024 · CIK: 1178879

Amicus Therapeutics, Inc. DEF 14A Filing Summary
FieldDetail
CompanyAmicus Therapeutics, Inc. (FOLD)
Form TypeDEF 14A
Filed DateApr 24, 2024
Risk Levellow
Pages16
Reading Time19 min
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, annual-meeting, esg

Related Tickers: AMTX

TL;DR

AMTX annual meeting June 6th, virtual. Vote your shares!

AI Summary

Amicus Therapeutics, Inc. is holding its 2024 Annual Meeting of Stockholders on June 6, 2024, at 9:00 a.m. EDT, virtually via webcast. Stockholders will receive the Notice of Annual Meeting, Proxy Statement, and the 2023 Annual Report. The company also encourages reviewing their 2024 ESG Report.

Why It Matters

This filing is important for stockholders to understand the company's performance in 2023 and the proposals to be voted on at the upcoming annual meeting, which can impact the company's future direction.

Risk Assessment

Risk Level: low — This is a standard proxy statement inviting shareholders to the annual meeting and providing related materials.

Key Players & Entities

  • Amicus Therapeutics, Inc. (company) — Registrant
  • June 6, 2024 (date) — Annual Meeting Date
  • 9:00 a.m. Eastern Daylight Time (time) — Annual Meeting Time

FAQ

When and where will the 2024 Annual Meeting of Stockholders be held?

The 2024 Annual Meeting of Stockholders will be held on Thursday, June 6, 2024, at 9:00 a.m. Eastern Daylight Time, in a virtual-only format via webcast.

What materials are being sent to stockholders?

Stockholders are being sent the Notice of Annual Meeting of Stockholders and Proxy Statement for 2024, the 2023 Annual Report to Stockholders (including the Annual Report on Form 10-K for fiscal year 2023), and a proxy card with a return envelope.

Where can stockholders find the 2024 ESG Report?

The 2024 Environmental, Social and Governance ("ESG") Report may be found through the Responsibility section of the company's website at www.amicusrx.com or at www.proxyvote.com.

What is the purpose of the Proxy Statement?

The Proxy Statement describes the business to be conducted at the meeting and provides information about Amicus Therapeutics, Inc. that stockholders should consider when voting their shares.

What is the filing form for this document?

This document is filed as a Schedule 14A (DEF 14A).

Filing Stats: 4,852 words · 19 min read · ~16 pages · Grade level 11.2 · Accepted 2024-04-24 16:31:08

Filing Documents

Executive Compensation

Executive Compensation The affirmative vote of a majority of the shares present or represented by proxy at the Annual Meeting and entitled to vote on such matter is required to adopt this resolution. Abstentions will have the effect of a vote against this proposal. Brokerage firms do not have the authority to vote customers' unvoted shares held by the firms in street name on this proposal and therefore are not entitled to vote on the matter. These broker non-votes will have no effect on the results of this vote. This advisory vote on executive compensation is not binding on our Board. However, the Board will take into account the result of the vote when determining future executive compensation arrangements. How are Votes Counted? Votes will be counted by the inspector of election appointed for the Annual Meeting, who will separately count "For", "Withhold" (with respect to the election of directors) and "Against" (with respect to proposals other than the election of directors) votes, abstentions, and broker non-votes. Who Will Pay the Costs of Soliciting these Proxies and How Are They Being Solicited? Amicus will pay all of the costs of soliciting these proxies. Our directors and employees may solicit proxies in person or by telephone, fax, or email. We will pay these employees and directors no additional compensation for these services. We will ask banks, brokers and other institutions, nominees, and fiduciaries to forward these proxy materials to their principals and to obtain authority to execute proxies. We will then reimburse them for their expenses. What Constitutes a Quorum for the Meeting? The presence, in person or by proxy, of the holders of a majority of the issued and outstanding shares of our Common Stock is necessary to constitute a quorum at the meeting. Votes of stockholders of record who are present at the meeting in person or by proxy, abstentions and broker non-votes are counted for purposes of determining whether a quorum exists. 4 TABL

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.